Abstract:OBJECTIVE:The bone marrow mesenchymal stem cells (BMSCs) have the capacity to differentiate into insulin-producing cells (IPCs) in vitro. However, low differentiation efficiency and poor maturity are the main obstacles. To investigate the feasibility of BMSCs differentiation into IPCs in diabetic pancreatic microenvironment of pigs. METHODS:BMSCs were isolated and purified from the bone marrow of a 4-week-old male pig. Fifteen female pigs (aged 8 to 10 weeks, weighing 8 to 10 kg) were randomly divided into 3 groups: normal control group (group A, n=5), diabetic control group (group B, n=5), and BMSCs transplanted group (group C, n=5). The pigs of groups B and C were treated by auris vein injections of streptozocin and alloxan for 3 days to induce diabetes mellitus (DM) model, whose blood glucose level 2 days all greater than 17 mmol/L was successful DM model. A total of 1.1 mL of the 3rd passage BMSCs labeled with enhanced green fluorescent protein (EGFP), with cell density of 5 x 10(7)/ mL, were injected into subcapsular pancreas of group C at multiple points, normal saline at the same dosage into those of groups A and B. After 30 days of monitoring blood glucose, the histological analysis of islet number and size were done; the immunofluorescence staining was used to detect the protein expression of insulin in the new-formed islets. The EGFP+ cells were collected from the sections using laser-capture microdissection; RT-PCR was used to detect insulin mRNA and pancreatic and duodenal homeobox factor 1 (PDX1) mRNA expressions from EGFP+ cells, and the insulin and sex determining region of the Y chromosome (SRY) genes were detected by fluorescence in situ hybridization (FISH). RESULTS:The blood glucose level decreased significantly in group C when compared with that in group B from 18 days and gradually decreased with time (P < 0.05). The histological observation showed that the number of islets was increased significantly in group C when compared with that in group B (10.9 +/- 2.2 vs. 4.6 +/- 1.4, P < 0.05), and there was no significant difference when compared with that in group A (10.9 +/- 2.2 vs.12.6 +/- 2.6, P > 0.05). The size of new-formed islets in group C was significantly smaller than that in group A [(47.2 +/- 19.6) microm vs. (119.6 +/- 27.7) microm, P < 0.05]. The immunofluorescence staining showed that new-formed islets of group C expressed insulin protein. RT-PCR showed that the microdissected EGFP+ cells of group C expressed insulin mRNA and PDX-1 mRNA. FISH showed that the new-formed islet cells of group C contained SRY gene in Y chromosome and insulin double positive cells. CONCLUSION:BMSCs can differentiate into IPCs in diabetic pancreatic microenvironment of pigs.

Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells.

[Differentiation of Bone Marrow Mesenchymal Stem Cells into Insulin Producing Cells Induced by Rat Injured Pancreatic Tissue Extract].

Effect of Htimp-1 Overexpression in Human Umbilical Cord Mesenchymal Stem Cells on the Repair of Pancreatic Islets in Type-1 Diabetic Mice

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Partially Repair Damaged Islets Of Diabetic Rat Model Via Insulin-Producing Cells Differentiated From Human Umbilical Cord Mesenchymal Stem Cells Infusion

The Effects of Transplantation of Bone Marrow Mesenchymal Stem Cells and Insulin Producing Cells from Them on Recipient Islets and Neovascularization

Repairment of Pancreas Mesenchymal Stem Cells on Injured Pancreas Tissues

[Feasibility of Bone Marrow Mesenchymal Stem Cells Differentiation in Diabetic Pancreatic Microenvironment].

IN VITRO TRANSDIFFERENTIATION OF RAT BONE MARROW MESENCHYMAL STEM CELLS INTO INSULIN-SECRETING CELLS

The impact of different microenvironments on the differentiation of rat bone marrow mesenchymal stem cells into insulin-producing cells

Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells.

Generation of Insulin-Producing Cells from C3H10T1/2 Mesenchymal Progenitor Cells

Transplantation of Mesenchymal Stem Cells Improves Type 1 Diabetes Mellitus

The role of the adipose tissue-derived mesenchymal stem cells enriched with melatonin in pancreatic cellular regeneration

Role of Bone Marrow-Derived Mesenchymal Stem Cells Differentiate into Β Cells in the Pancreatic Microenvironment

Stndy on Diabetic Rat Therapy by Islet Transplantation with Rat Mesenchymal Stem Cells and Scaffold of Pig Small Intestinal Submucosal

Bone Marrow Mesenchymal Stem Cells Orthotopictransplantation Reverse Diabetes

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

Repair of Injured Pancreatic Tissue of Rats with Transplanted Marrow Derived Mesenchymal Stem Cells

Coexpression of Pdx1 and betacellulin in mesenchymal stem cells could promote the differentiation of nestin-positive epithelium-like progenitors and pancreatic islet-like spheroids.

Cultivation, Identification and Islet β Cells Induction of Bone Marrow Mesenchymal Stem Cells in Rats